BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 8973787)

  • 1. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of manidipine on blood pressure and renal function in salt-loaded, spontaneously hypertensive rats.
    Ikenaga H; Suzuki H; Saruta T
    Blood Press Suppl; 1992; 3():75-9. PubMed ID: 1343295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
    Muratani H; Takishita S; Kawazoe N; Tozawa M; Fukiyama K
    Blood Press Suppl; 1992; 3():60-7. PubMed ID: 1343293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
    Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
    Galceran J; Plana J; Felip A; Pou G; Vila J; Sobrino J
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the efficacy and safety of manidipine in hypertensive patients with renal disorders.
    Mizuno K; Haga H; Takahashi M; Watanabe Y; Fukuchi S
    Blood Press Suppl; 1992; 3():119-23. PubMed ID: 1343279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
    Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T; Kanno Y; Hayashi K; Konishi K
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the calcium antagonist manidipine on renal hemodynamics and function in dogs: comparison with nifedipine.
    He H; Tamaki T; Aki Y; Kiyomoto H; Iwao H; Miyatake A; Abe Y
    Blood Press Suppl; 1992; 3():68-74. PubMed ID: 1343294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification by dihydropyridine-type calcium antagonists of the renal hemodynamic response to vasoconstrictors.
    Loutzenhiser R; Epstein M; Horton C
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S70-5. PubMed ID: 2441189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
    Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a calcium channel blocker, manidipine hydrochloride, on the regulatory mechanism of glomerular capillary pressure in SHR.
    Onuki T
    Nihon Jinzo Gakkai Shi; 1995 Feb; 37(2):119-26. PubMed ID: 7752503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles.
    Kimura K; Tojo A; Hirata Y; Hayakawa H; Goto A; Omata M
    Blood Press Suppl; 1994; 5():71-4. PubMed ID: 7889206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of manidipine on renal blood flow and sympathetic nerve activity in conscious, spontaneously hypertensive rats.
    Takishita S; Muratani H; Kawazoe N; Tozawa M; Kimura Y; Fukiyama K
    Blood Press Suppl; 1992; 3():53-9. PubMed ID: 1343291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.